:

Lei Cao1, Xu Lu1, Xia Wang1

  • 1Department of Oncology, The Affiliated Suqian First People's Hospital of Nanjing Medical University, Suqian, China.

Frontiers in immunology
|October 2, 2024
PubMed
概括

这项研究确定了结质瘤干细胞 (GSC) 和它们与髓状细胞衍生抑制细胞 (MDSC) 的相互作用,开发了一种新的预后特征 (GSCS),以改善结质瘤患者的治疗结果. 图巴1C基因显示了治疗潜力.